Archive March 2013

Lonza CEO says reviewing biosimilar venture with Teva

Lonza CEO says reviewing biosimilar venture with Teva

Published 30/03/2013

ZURICH (Reuters) - Swiss specialty chemicals and life sciences group Lonza is reviewing whether it is still worth investing in its joint venture with Teva [more…]

Public pension holdings highest since 2007 peak: U.S. Census

Published 29/03/2013

NEW YORK (Reuters) - Public pensions reached a milestone in the fourth quarter of 2012 when assets rose to the highest since a peak just [more…]

U.S. public pension holdings highest since 2007 peak: Census

Published 28/03/2013

NEW YORK (Reuters) - U.S. public pensions reached a milestone in the fourth quarter of 2012 when assets rose to the highest since a peak [more…]

Aluminum meltdown- the preview

Published 28/03/2013

LONDON (Reuters) - How will it all end? It's a question the Aluminum market has been asking itself for months now. Here's a global industry, [more…]

Cyprus is very special case, found right solution: German finance minister

Published 28/03/2013

BERLIN (Reuters) - German Finance Minister Wolfgang Schaeuble said on Thursday Cyprus was a very special case and the European Union had found the right [more…]

Small businesses spell big problems for Italy and Spain

Published 28/03/2013

MILAN/MADRID (Reuters) - Small companies struggling to repay loans in Italy and Spain signal bigger problems on the horizon for the euro zone after the [more…]

UK scientists develop safer foot-and-mouth vaccine

UK scientists develop safer foot-and-mouth vaccine

Published 28/03/2013

LONDON (Reuters) - British scientists have developed a new vaccine against foot-and-mouth disease that is safer and easier to manufacture, an advance they believe should [more…]

Pfizer gets new rebuff from UK cost body for cancer drug

Pfizer gets new rebuff from UK cost body for cancer drug

Published 28/03/2013

LONDON (Reuters) - Pfizer suffered a second rejection in two days from Britain's health cost watchdog NICE as its new kidney cancer drug Inlyta was [more…]

FDA approves Biogen’s oral MS drug, Tecfidera

FDA approves Biogen’s oral MS drug, Tecfidera

Published 27/03/2013

WASHINGTON (Reuters) - U.S. regulators on Wednesday approved a new multiple sclerosis drug made by Biogen Idec Inc that is widely expected to become the [more…]

British ex-policeman, prison officer jailed in hacking case

Published 27/03/2013

LONDON (Reuters) - Two former policemen and an ex-prison officer were jailed on Wednesday for selling stories to Rupert Murdoch's tabloid the Sun, Britain's top-selling [more…]